OLHHA is a dual CB1 receptor antagonist and PPARα agonist. OLHHA also is a alcohol intake inhibitor with an EC50 value of 0.2 mg/kg. OLHHA reduces both hepatic lipid accumulation and circulating triglyceride levels. OLHHA shows anti-steatotic activity and has the potential for the research of non-alcoholic fatty liver disease (NAFLD)[1][2].

OLIG1 Human Pre-designed siRNA Set A contains three designed siRNAs for OLIG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OLIG2 Human Pre-designed siRNA Set A contains three designed siRNAs for OLIG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OLIG3 Human Pre-designed siRNA Set A contains three designed siRNAs for OLIG3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Oligomycin E is a antitumor antibiotic that can be isolated from Streptomyces. Oligomycin E has significant antifungal activity, showing minimal inhibitory concentrations (MICs) values between 2 and 75μg/mL. Oligomycin E has strong antitumor activity against HeLa cells, with an IC50 of 0.014 μg/mL[1].

TD139 is an inhaled galectin-3 inhibitor with a Kd of 14 nM.

TD139 is an inhaled galectin-3 inhibitor with a Kd of 14 nM.

TD139 is an inhaled galectin-3 inhibitor with a Kd of 14 nM.

TD139 is an inhaled galectin-3 inhibitor with a Kd of 14 nM.

TD139 is an inhaled galectin-3 inhibitor with a Kd of 14 nM.

Olopatadine (hydrochloride) (Standard) is the analytical standard of Olopatadine (hydrochloride). This product is intended for research and analytical applications.

Olorofim (F901318) selectively inhibits fungal dihydroorotate dehydrogenase (DHODH), a key enzyme in the pyrimidine biosynthesis pathway. Olorofim (F901318). Olorofim exhibits excellent activity against A. fumigatus and other Aspergillus spp.[1].

Olorofim (F901318) selectively inhibits fungal dihydroorotate dehydrogenase (DHODH), a key enzyme in the pyrimidine biosynthesis pathway. Olorofim (F901318). Olorofim exhibits excellent activity against A. fumigatus and other Aspergillus spp.[1].

Olorofim (F901318) selectively inhibits fungal dihydroorotate dehydrogenase (DHODH), a key enzyme in the pyrimidine biosynthesis pathway. Olorofim (F901318). Olorofim exhibits excellent activity against A. fumigatus and other Aspergillus spp.[1].

Olorofim (F901318) selectively inhibits fungal dihydroorotate dehydrogenase (DHODH), a key enzyme in the pyrimidine biosynthesis pathway. Olorofim (F901318). Olorofim exhibits excellent activity against A. fumigatus and other Aspergillus spp.[1].

Olorofim (F901318) selectively inhibits fungal dihydroorotate dehydrogenase (DHODH), a key enzyme in the pyrimidine biosynthesis pathway. Olorofim (F901318). Olorofim exhibits excellent activity against A. fumigatus and other Aspergillus spp.[1].

OLR1 Human Pre-designed siRNA Set A contains three designed siRNAs for OLR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Olsalazine-d3 is deuterated labeled Olsalazine (HY-B0174A). Olsalazine is a potent inhibitor of macrophages chemotaxis to LTB4 with an IC50 value of 0.39 mM, also reduces the synthesis of 5-hydroxyeicosatetraenoic acid (5-HETE), 11-HETE, 12-HETE, and 15-HETE in polymorphonuclear leukocyte (PMNL) and mononuclear cells (MNL). Olsalazine can be used for researching ulcerative colitis. Anti-inflammatory activity[1][2].

Olsalazine-d3,15N is 15N and deuterated labeled Olsalazine (HY-B0174A). Olsalazine is a potent inhibitor of macrophages chemotaxis to LTB4 with an IC50 value of 0.39 mM, also reduces the synthesis of 5-hydroxyeicosatetraenoic acid (5-HETE), 11-HETE, 12-HETE, and 15-HETE in polymorphonuclear leukocyte (PMNL) and mononuclear cells (MNL). Olsalazine can be used for researching ulcerative colitis. Anti-inflammatory activity[1][2].

OMA1 Human Pre-designed siRNA Set A contains three designed siRNAs for OMA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OMD Human Pre-designed siRNA Set A contains three designed siRNAs for OMD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Omeprazole-d3 sodium is deuterated labeled Omeprazole (HY-B0113). Omeprazole (H 16868), a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders. Omeprazole shows competitive inhibition of CYP2C19 activity with a Ki of 2 to 6 μM[1]. Omeprazole also inhibits growth of Gram-positive and Gram-negative bacteria[2].Omeprazole is a potent brain penetrant neutral sphingomyelinase (N-SMase) […]

OMG Human Pre-designed siRNA Set A contains three designed siRNAs for OMG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OMP Human Pre-designed siRNA Set A contains three designed siRNAs for OMP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Omphalotin A is a cyclic peptide, and shows nematicidal activity[1].

OMS14 is exhibits inhibitory activity for phosphoinositide 3-kinase γ (PI3Kγ) and PIK3CD/PIK3R1, which inhibits 19% PI3Kγ and 65% PIK3CD/PIK3R1 activity at 100 μM. OMS14 exhibits anticancer efficacy in various cancer cells[1].

ONECUT1 Human Pre-designed siRNA Set A contains three designed siRNAs for ONECUT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ONECUT2 Human Pre-designed siRNA Set A contains three designed siRNAs for ONECUT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ONECUT3 Human Pre-designed siRNA Set A contains three designed siRNAs for ONECUT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OOEP Human Pre-designed siRNA Set A contains three designed siRNAs for OOEP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPA1 Human Pre-designed siRNA Set A contains three designed siRNAs for OPA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPA3 Human Pre-designed siRNA Set A contains three designed siRNAs for OPA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPALIN Human Pre-designed siRNA Set A contains three designed siRNAs for OPALIN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPCML Human Pre-designed siRNA Set A contains three designed siRNAs for OPCML gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ophiocordylongiiside A is a compound found in Polyphilus sieberi. Ophiocordylongiiside A shows activity against the free-living nematode Caenorhabditis elegans[1].

OPHN1 Human Pre-designed siRNA Set A contains three designed siRNAs for OPHN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPLAH Human Pre-designed siRNA Set A contains three designed siRNAs for OPLAH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPN1LW Human Pre-designed siRNA Set A contains three designed siRNAs for OPN1LW gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPN1MW Human Pre-designed siRNA Set A contains three designed siRNAs for OPN1MW gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPN1SW Human Pre-designed siRNA Set A contains three designed siRNAs for OPN1SW gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPN3 Human Pre-designed siRNA Set A contains three designed siRNAs for OPN3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPN4 Human Pre-designed siRNA Set A contains three designed siRNAs for OPN4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPN5 Human Pre-designed siRNA Set A contains three designed siRNAs for OPN5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPRD1 Human Pre-designed siRNA Set A contains three designed siRNAs for OPRD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPRK1 Human Pre-designed siRNA Set A contains three designed siRNAs for OPRK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OPRL1 Human Pre-designed siRNA Set A contains three designed siRNAs for OPRL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.